INCY
Incyte CorporationNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$21.68B
P/E Ratio
15.33
EPS
$7.08
Beta
0.79
52W High
$112.29
52W Low
$66.74
50-Day MA
$97.80
200-Day MA
$96.50
Dividend Yield
—
Profit Margin
26.70%
Forward P/E
14.10
PEG Ratio
0.36
About Incyte Corporation
Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware.
Fundamentals
| Revenue (TTM) | $5.36B |
| Gross Profit (TTM) | $2.83B |
| EBITDA | $1.55B |
| Operating Margin | 25.60% |
| Return on Equity | 30.80% |
| Return on Assets | 13.90% |
| Revenue/Share (TTM) | $27.27 |
| Book Value | $28.12 |
| Price-to-Book | 3.86 |
| Price-to-Sales (TTM) | 4.04 |
| EV/Revenue | 3.303 |
| EV/EBITDA | 9.46 |
| Quarterly Earnings Growth (YoY) | 83.80% |
| Quarterly Revenue Growth (YoY) | 20.90% |
| Shares Outstanding | $199.78M |
| Float | $167.50M |
| % Insiders | 1.89% |
| % Institutions | 106.58% |
Historical Volatility
HV 10-Day
43.85%
HV 20-Day
33.68%
HV 30-Day
30.29%
HV 60-Day
28.78%
HV Rank
38.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($109.09 target)
2
Strong Buy9
Buy15
Hold1
Sell1
Strong SellMore HEALTHCARE Stocks
Data last updated: 6/13/2026